Range Low Price High Price Comment
30 days $9.09 $9.09 Friday, 22nd Sep 2023 CTIC stock ended at $9.09. During the day the stock fluctuated 0% from a day low at $9.09 to a day high of $9.09.
90 days $9.09 $9.09
52 weeks $4.01 $9.10

Historical CTI BioPharma Corp. prices

Date Open High Low Close Volume
Jan 29, 2016 $12.00 $13.00 $11.70 $12.60 568 980
Jan 28, 2016 $12.00 $12.20 $11.60 $11.90 144 710
Jan 27, 2016 $12.30 $12.30 $11.80 $12.00 125 820
Jan 26, 2016 $12.00 $12.60 $11.80 $12.60 191 470
Jan 25, 2016 $11.30 $12.30 $11.30 $12.30 193 410
Jan 22, 2016 $11.30 $11.80 $11.30 $11.60 76 840
Jan 21, 2016 $11.10 $11.60 $10.80 $11.30 139 630
Jan 20, 2016 $11.00 $11.60 $10.80 $11.40 185 630
Jan 19, 2016 $11.50 $11.70 $11.20 $11.50 222 270
Jan 15, 2016 $11.60 $11.90 $11.40 $11.90 134 820
Jan 14, 2016 $11.90 $12.40 $11.40 $12.00 198 460
Jan 13, 2016 $12.60 $12.60 $11.80 $11.80 134 910
Jan 12, 2016 $12.00 $12.90 $11.80 $12.80 360 170
Jan 11, 2016 $12.30 $12.30 $11.50 $11.90 211 040
Jan 08, 2016 $11.90 $12.10 $11.70 $12.00 154 050
Jan 07, 2016 $12.00 $12.20 $11.50 $12.00 285 980
Jan 06, 2016 $12.40 $12.50 $12.10 $12.20 136 160
Jan 05, 2016 $12.80 $13.20 $12.30 $12.70 219 510
Click to get the best stock tips daily for free!

About CTI BioPharma Corp.

CTI BioPharma CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.;... CTIC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT